Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
1.260
0.00 (0.00%)
At close: Nov 20, 2024, 4:00 PM
1.400
+0.140 (11.10%)
After-hours: Nov 20, 2024, 7:57 PM EST

Theriva Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
--18.35-19.69-14.27-10.04-15.3
Upgrade
Depreciation & Amortization
-0.140.090.090.20.24
Upgrade
Stock-Based Compensation
-0.550.480.420.350.34
Upgrade
Other Operating Activities
--3.640.850.170.11-0.01
Upgrade
Change in Accounts Payable
--0.16-0.39-0.36-1.431.28
Upgrade
Change in Other Net Operating Assets
-2.47-0.421.07-1.35-0.43
Upgrade
Operating Cash Flow
--19-19.08-12.89-12.17-13.87
Upgrade
Capital Expenditures
--0.2-0.12-0.01-0.01-
Upgrade
Cash Acquisitions
---3.86---
Upgrade
Investing Cash Flow
--0.2-4.4-0.01-0.01-
Upgrade
Long-Term Debt Repaid
--0.08-1.38---
Upgrade
Net Debt Issued (Repaid)
--0.08-1.38---
Upgrade
Issuance of Common Stock
-2.22-743.36-
Upgrade
Repurchase of Common Stock
---0.29---
Upgrade
Other Financing Activities
--1.52-3---
Upgrade
Financing Cash Flow
-0.63-1.93743.36-
Upgrade
Foreign Exchange Rate Adjustments
--0.03-0.03---
Upgrade
Net Cash Flow
--18.61-25.4461.1-8.82-13.87
Upgrade
Free Cash Flow
--19.2-19.2-12.9-12.18-13.87
Upgrade
Free Cash Flow Per Share
--29.80-31.31-26.47-160.13-210.99
Upgrade
Levered Free Cash Flow
--14.4-10.42-7.51-8.3-8.25
Upgrade
Unlevered Free Cash Flow
--14.4-10.42-7.51-8.3-8.25
Upgrade
Change in Net Working Capital
1.021.09-1.16-0.932.67-0.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.